E-LIB Suche - Ergebnisse für: Iveson, Timothy J

1

Codon-specific KRAS mutations predict survival benefit of t..:

van de Haar, Joris ; Ma, Xuhui ; Ooft, Salo N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033412/. , 2023

Link: http://www.ncbi.nlm.nih...

2

SCOT: tumour sidedness and the influence of adjuvant chemot..:

Saunders, Mark P ; Iype, Rohan ; Kelly, Caroline...
https://eprints.gla.ac.uk/292283/1/292283.pdf. , 2023

Link: https://eprints.gla.ac.u..

3

Codon-specific KRAS mutations predict survival benefit of t..:

van de Haar, Joris ; Ma, Xuhui ; Ooft, Salo N...
info:eu-repo/semantics/altIdentifier/pmid/36864254. , 2023

Link: https://hdl.handle.net/1..

4

The early impact of the IDEA collaboration results: how the..:

Iveson, Timothy ; Hanna, Catherine ; Iveson, Poppy...
http://eprints.gla.ac.uk/242543/1/242543.pdf. , 2021

Link: http://eprints.gla.ac.uk..

5

Duration of adjuvant doublet chemotherapy (3 or 6 months) i..:

Iveson, Timothy J ; Sobrero, Alberto F ; Yoshino, Takayuki...
http://eprints.gla.ac.uk/224253/2/224253.pdf. , 2021

Link: http://eprints.gla.ac.uk..

6

Do clinical trials change practice? A longitudinal, interna..:

Hanna, Catherine R ; Boyd, Kathleen A ; Wincenciak, Joanna...
https://eprints.gla.ac.uk/249425/1/249425.pdf. , 2021

Link: https://eprints.gla.ac.u..

7

Early-Onset Colorectal Adenocarcinoma in the IDEA Database:..:

Fontana, Elisa ; Meyers, Jeff ; Sobrero, Alberto...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677996/. , 2021

Link: http://www.ncbi.nlm.nih...

8

Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) i..:

Iveson, Timothy J ; Sobrero, Alberto F ; Yoshino, Takayuki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078416/. , 2021

Link: http://www.ncbi.nlm.nih...

9

Effect of duration of adjuvant chemotherapy for patients wi..:

André, Thierry ; Meyerhardt, Jeffrey ; Iveson, Timothy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786835/. , 2020

Link: http://www.ncbi.nlm.nih...

10

Effect of duration of adjuvant chemotherapy for patients wi..:

André, Thierry ; Meyerhardt, Jeffrey A ; Iveson, Timothy...
https://eprints.soton.ac.uk/446187/1/IDEA_OS_manu_LO_rev3_2020_Aug_19_clean.docx. , 2020

Link: https://eprints.soton.ac..

11

Systemic chemotherapy with or without cetuximab in patients..:

Bridgewater, John A ; Pugh, Siân A ; Maishman, Tom...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052737/. , 2020

Link: http://www.ncbi.nlm.nih...

12

Outcomes and survival following neoadjuvant chemotherapy ve..:

Pucher, Philip H ; Rahman, Saqib ; Walker, Robert...
https://eprints.soton.ac.uk/442032/1/CRT_v_CT_paper_final_rev2_no_track_changes.docx. , 2020

Link: https://eprints.soton.ac..

13

Effect of duration of adjuvant chemotherapy for patients wi..:

André, Thierry ; Meyerhardt, Jeffrey ; Iveson, Timothy...
http://eprints.gla.ac.uk/275039/1/275039.pdf. , 2020

Link: http://eprints.gla.ac.uk..

14

Systemic chemotherapy with or without cetuximab in patients..:

Bridgewater, John ; Pugh, Siân A ; Maishman, Tom...
https://eprints.soton.ac.uk/437424/1/19TLO1227_Primrose_proof_revised4_LS.pdf. , 2020

Link: https://eprints.soton.ac..

15

Aspirin as an adjuvant treatment for cancer: feasibility re..:

Joharatnam-Hogan, Nalinie ; Cafferty, Fay ; Hubner, Richard...
https://eprints.soton.ac.uk/434429/1/Lancet_GH_Add_Aspirin_Feasibility_Toxicity_Paper_revised_clean_002_.docx. , 2019

Link: https://eprints.soton.ac..